L’implication du CD154 résistant au clivage enzymatique dans l’activité anti-tumorale
Main Author: | |
---|---|
Other Authors: | |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/1866/18915 |
Main Author: | |
---|---|
Other Authors: | |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/1866/18915 |